Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology

Exposure to cannabinoids may exacerbate the psychological consequences of trauma

by Eric W. Dolan
July 30, 2018
in Psychopharmacology
(Photo credit: Sebastian Kaulitzki)

(Photo credit: Sebastian Kaulitzki)

Share on TwitterShare on Facebook
Stay on top of the latest psychology findings: Subscribe now!

Synthetic cannabinoids can increase depression- and anxiety-like behaviors in a rodent model of trauma, according to new research in European Neuropsychopharmacology.

“Brenda Sbarski, one of my master students, was very much interested to find out how pre-trauma exposure to cannabinoids affect the response to a traumatic event. All of our studies were conducted on rats with no prior exposure to cannabinoids (before the trauma) and she thought that this may not represent the human condition correctly,” said study author Irit Akirav of the University of Haifa.

The researchers were interested in learning whether chronic exposure to a cannabinoid receptor agonist before experiencing trauma would have a therapeutic effect or would exacerbate the negative consequences of trauma.

In their experiments, rats were administered the synthetic CB1/2 receptor agonist WIN55,212–2 for twelve days before being subjected to an inescapable electric shock.

Exposure to the cannabinoid receptor agonist enhanced fear retrieval and impaired fear extinction, and also increased immobility in a forced swimming test — behaviors that reflect anxiety and depression, respectively. But it was also found to have a therapeutic effect in a startle test.

The key finding is that “chronic exposure to drugs that activate CB1 receptors before being exposed to a traumatic event might have deleterious effects on the emotional response to the trauma (compared to subjects that were not expose to cannabinoids before the trauma),” Akirav told PsyPost.

“We need to study what happens when we administer cannabinoids after trauma exposure to subjects that were already exposed to cannabinoids before trauma exposure. Will they need a different treatment than the non pre-trauma exposed subjects?”

“The effects may be specific to CB1 receptor activation,” she added. “It could be that other cannabinoids (not directly activating the CB1 receptor) may have different (better?) effects on the response to the trauma.”

The study, “Chronic exposure to cannabinoids before an emotional trauma may have negative effects on emotional function“, was authored by Brenda Sbarski and Irit Akirav.

TweetSendScanShareSendPinShareShareShareShareShare

RELATED

A surprising body part might provide key insights into schizophrenia risk
Addiction

Neuroscientists shed new light on how heroin disrupts prefrontal brain function

July 11, 2025

After heroin exposure and abstinence, mice showed reduced prefrontal brain activity during social interaction but heightened responses to drug-related cues, suggesting heroin disrupts normal brain function in ways that may contribute to social withdrawal and relapse risk.

Read moreDetails
Loss of empathy in frontotemporal dementia traced to weakened brain signals
ADHD

Adults treated with psychostimulants for ADHD show increased brain surface complexity, study finds

July 10, 2025

Researchers have discovered that long-term psychostimulant use in adults with ADHD is associated with increased brain surface complexity, yet these anatomical differences appear unrelated to clinical outcomes, according to a study using high-resolution MRI data from UCLA.

Read moreDetails
Little-known psychedelic found to have a fascinating effect on cognitive flexibility after just a single dose
Psychedelic Drugs

Fascinating new advances in psychedelic science reveal how they may heal the mind

July 9, 2025

A series of recent studies has begun to map the specific neural, cognitive, and emotional processes that psychedelics influence—often in ways that challenge long-held assumptions

Read moreDetails
Ketamine repairs reward circuitry to reverse stress-induced anhedonia
Depression

Ketamine repairs reward circuitry to reverse stress-induced anhedonia

July 9, 2025

New research shows a single low, non-anesthetic dose of ketamine revived pleasure seeking in chronically stressed mice by restoring weakened excitatory synapses onto nucleus accumbens dopamine D1 neurons, pinpointing a circuit mechanism for the drug’s rapid antidepressant effect.

Read moreDetails
Use of mescaline may facilitate unintended improvements in several psychiatric conditions, study suggests
Ayahuasca

Many ayahuasca users report challenging experiences—yet some are linked to better mental health

July 4, 2025

Are challenging ayahuasca experiences always harmful? Not necessarily, finds a new global survey. While some effects predict poorer mental health, others like visual distortions are linked to positive outcomes, highlighting the crucial role of context and individual vulnerability.

Read moreDetails
Taking medicinal cannabis oil for insomnia does not impair cognition on the following day
Cannabis

Cannabis oil might help with drug-resistant epilepsy, study suggests

July 2, 2025

Nineteen patients with drug-resistant epilepsy experienced seizure freedom after cannabis oil treatment, with a median seizure-free duration of 245 days. Five remained seizure-free for over a year, and most reported improved quality of life and reduced seizure frequency.

Read moreDetails
Psychedelic compound blurs boundary between self and others in the brain, study finds
Ayahuasca

Psychedelic compound blurs boundary between self and others in the brain, study finds

July 2, 2025

A recent study found that a DMT/harmine formulation blurs the brain’s distinction between self and other faces, disrupting self-referential processing while preserving recognition of familiar faces, suggesting a neural basis for psychedelic-induced ego dissolution.

Read moreDetails
Researchers identify neural mechanism behind memory prioritization
MDMA

New study reveals how MDMA rewires serotonin and oxytocin systems in the brain

June 30, 2025

Researchers found that MDMA reduces anxiety and enhances social behavior in zebrafish by altering key neurochemical systems. The drug suppressed serotonin signaling, boosted oxytocin receptor expression, and modulated brain signaling proteins involved in emotional regulation.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Neuroscientists shed new light on how heroin disrupts prefrontal brain function

New research identifies four distinct health pathways linked to Alzheimer’s disease

A surprising body part might provide key insights into schizophrenia risk

Religious belief linked to lower anxiety and better sleep in Israeli Druze study

A common vegetable may counteract brain changes linked to obesity

Massive psychology study reveals disturbing truths about Machiavellian leaders

Dementia: Your lifetime risk may be far greater than previously thought

Psychopathic tendencies may be associated with specific hormonal patterns

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy